Skip to main content

1st Webinar 11th November 2023

We held our first Webinar on 11th November 2023 via Zoom - videos of the presentations can be found here:-

-  Cilia and the role they play in the human body from Amelia Shoemark

Bendert De Graaf'spersonal story and about the BBS Group in the Nederlands and about Project Predict

-  Plans for the Ciliopathy Alliance UK over the next few years by Fiona Copeland, Trustee of the Ciliopathy Alliance

Our next webinar is planned for May 2024 - please let us know if there are any specific subjects you would like us to cover.

 

 

 

AGM 21st OCTOBER 2025

We held our AGM on Tuesday, 21st October 2025 online.

It was a great oppportunity to welcome our two new Trustees, Audrey Hughes and Rhoda Akilapa.  We also spent some time discussing the work we are planning this year.

To read our annual report click here.

To read the minutes of the AGM click here.

Any queries then please contact us.

 

 

Alström Syndrome UK is pleased to join Genetic Alliance UK’s Future for Rare Steering Group

Alström Syndrome UK is pleased to join Genetic Alliance UK’s Future for Rare Steering Group. Together, we are taking a leading role in shaping the future of rare conditions policy in the UK.

The Future for Rare survey is designed to capture a comprehensive picture of the current experiences and priorities of the genetic, rare and undiagnosed community across the UK.

We welcome views from everyone, whether you are living with a genetic, rare and undiagnosed condition, caring for a loved one, or working for a support organisation, as a researcher or a healthcare professional. Every perspective is valued equally and will directly inform our recommendations to all four governments.

Share your experiences via the Future for Rare survey.

Please submit your response by Friday 24 April 2026.

For more information on how this information will inform the campaign, please visit the Future for Rare webpage.

 

Cilia2024 Sept 10-13 Dublin

Cilia2024 (hybrid) is the 6th running of the biennial European Cilia research meeting, taking place on September 10-13 in Dublin, Ireland. As the world’s largest scientific meeting for cilia and flagella research, Cilia2024 will bring together cilia researchers, clinicians, patients and patient representatives from across the globe, partaking in a wide ranging programme incorporating 11 scientific sessions, 4 keynote lectures, 35+ oral presentations, 22 flash talks and 3 poster sessions. Cilia2024 will also provide an elevated forum for patient-scientist-pharma exchange via a specific Patient Event on Sept 09 and 10.  We do hope you will join us!

Registration for Researchers and Clinicians

Registration for Patients and Carers

 

Cilia24 Dublin

We held a patient meeting ahead of the main meeting and a number of clinicians and researches were invited to join our 'World Cafe'.  This gave us the opportunity to work together on the most pressing issues of the Ciliopathy patient community.  Over 70 of us, were given themes to talk about and there was no shortage of ideas.

We followed this up with a Q&A session with clinicians and researchers.

Future for Rare Disease Workshop - June 2026

On 11 June 2026, Ciliopathy Alliance, in partnership with Genetic Alliance UK, hosted a community workshop to gather input on the future of the UK Rare Diseases Framework. Bringing together patients, families, carers, researchers and charity representatives, the session explored whether current priorities—such as faster diagnosis, improved awareness, better care coordination, and access to specialist treatments—remain fit for purpose. 

Notice of 12th AGM - 7 December 2023

Our Annual General Meeting will be held online on Thursday, 7th December 2023 from 11.30 a.m. to 12.30 p.m.

Agenda:-

  1. Apologies for absence.
  2. To approve the minutes of the 11th Annual General Meeting held on 1 December 2022.
  3. To receive the Board’s Accounts for the period 1 April 2022 to 31 March 2023.
  4. Chair’s Annual Report.
  5. Approve the appointment of Mrs. Kerry Leeson-Beevers as a member of the Board for a term of 3 years.
  6. Approve the reappointment of Dr. Elizabeth Forsythe as a member of the Board for a 2nd term of 3 years.
  7. Approve the membership applications of Beth Cutting, Marina Arbi, Stephen White (CureUsher), Chloe Joyner (Usher Kids UK) and Faryal Ijaz.

Online Workshop helping to shape the Future for Rare Policy

Genetic Alliance UK – UK Rare Diseases Framework Consultation

Join us on Thursday, 11th June 2026 from 12 noon to 2 p.m. to help Genetic Alliance develop practical and realistic policies for Rare Diseases to feedback to the UK Government. We want to ensure that the voices of the Ciliopathy community are heard so would welcome, people with lived experience, support groups, researchers and clinicians to join us for this important workshop.

Register here for the meeting

Rare Disease Day House of Commons 29th February 2024

The Ciliopathy Alliance had a great afternoon at the Houses of Parliament as guests of Rare Disease UK where Andrew Stephenson (Minister for Health and Secondary Care) launched the governments plan to continue supporting patients with Rare Diseases.  The standout points were the piloting of Syndromes Without a Name clinics for people with rare undiagnosed conditions and the 'Generation Study' where newborn babies witll be screended for rare diseases. 

It was also a great opportunity for  us to catch up with old friends and colleagues from the Rare Disease community. 

 

 

 

 

Reflections from the UK Cilia and Centrosome Network Meeting June 2025

On Friday, 20th June 2025 -  some of our Trustees attended the UK Cilia and Centrosome Network Meeting which was hosted by Hannah Mitchison our Chair.  Thanks to Kerry Leeson-Beavers  for updating the group about the CAUK's strategy. 

It was Temi's first Cilia Scientific Meeting (as Treasurer of the Ciliopathy Alliance UK)  - here are her reflections:-

Earlier this month, I had the opportunity to attend the UK Cilia & Centrosome Network Conference. As someone with a background in biochemistry and a professional focus on digital and AI transformation, I found the conference both intellectually stimulating and deeply affirming.